#Arrivées et nominations
jeu 19/11/2026
ELSAN appoints Mehdi Ghissassi to its Supervisory Board to support its ambitions in artificial intelligence
A former Google DeepMind and Google Brain executive and a recognized expert in developing artificial intelligence solutions, Mehdi Ghissassi will bring to the Group his international experience in technological innovation and organizational transformation,
to support the acceleration of ELSAN’s AI strategy.
A proven track record at Google and Google DeepMind
Mehdi Ghissassi joined Google in 2012, where he worked in particular on Google Cloud and on developing products for emerging markets. From 2016 to 2024, he built and led the product team at DeepMind, and then the product team at Google Brain.
He began his career in consulting at Booz & Company, before moving into investment at Macquarie. Since 2024, Mehdi Ghissassi is the Chief Product & Technology Officer at Ai71, an artificial intelligence scale-up based in Abu Dhabi.
With extensive experience in AI strategy and product development, he has led engineering teams to bring cutting-edge research into products used worldwide. He therefore has an in-depth understanding of what it takes to move from technological innovation to large-scale operational use. He has notably specialized in agentic AI: systems capable of carrying out a sequence of tasks within a process, under human supervision.
His career, built in highly international environments (Europe, the United States, Africa, Asia and the Middle East), thus combines technological expertise, product development and operational deployment.
Mehdi Ghissassi currently also sits on several boards, including that of Teleperformance, where he chairs the AI & Innovation Committee.
Mehdi Ghissassi holds a double engineering degree from École polytechnique and École nationale des ponts et chaussées, a Master in International Affairs from Sciences Po Paris and an MBA from Columbia Business School.
ELSAN: placing artificial intelligence at the service of healthcare
True to its purpose, “Act responsibly and innovatively to provide healthcare everywhere”, ELSAN has always harnessed innovation for the benefit of patients and healthcare professionals. Today, the Group is taking a new step forward, with the ambition of becoming, by 2030, a European benchmark for the large-scale deployment of useful and responsible AI in the hospital sector, for the benefit of patients and healthcare professionals, but also of the efficiency of its organizations and, more broadly, the sustainability of the healthcare system.
As France’s leading private hospital group, ELSAN will in particular aim to simplify patient procedures, make processes more reliable and ease certain administrative tasks, through an approach that puts data protection, human accountability and support for teams first.
Sébastien Proto, CEO of the ELSAN Group, said:
“We are delighted to welcome Mehdi Ghissassi to ELSAN’s Supervisory Board. His tenure at Google DeepMind and Google Brain, his expertise in developing AI solutions and his international experience are valuable assets for the Group. Mehdi has that essential ability to turn the most innovative technological advances into concrete solutions that serve users and organizations.
Our first AI deployments, for example in assisting fracture detection in radiology or in analyzing patient feedback, provide a solid foundation for accelerating. This new phase builds on our teams and in-house capabilities to gradually roll out, across our facilities and support functions, the use cases that have proven their benefits.
Our ambition is clear: to make ELSAN a European benchmark for the deployment of AI at scale in the hospital sector, serving patients, healthcare professionals and the healthcare system.”
Mehdi Ghissassi added:
“I am honored to join ELSAN’s Supervisory Board. Healthcare is one of the fields in which artificial intelligence can deliver the most useful advances, provided we start from the needs of patients, healthcare professionals and the healthcare system, and deploy solutions with rigor, responsibility and pragmatism. I look forward to contributing to the Board’s thinking and helping to inform the Group’s strategic choices, combining ambition, responsibility and practical value.”
Share
Contact
Pour plus d'informations:
news@elsan.care


